Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation
Cells · 2024
DOI: 10.3390/cells13040309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Anna Flavia Cantone und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmacology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, Nicotinic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Research.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD), marked by cognitive impairment, predominantly affects the brain regions regulated by cholinergic innervation, such as the cerebral cortex and hippocampus. Cholinergic dysfunction, a key contributor to age-related cognitive decline, has spurred investigations into potential therapeutic interventions. We have previously shown that choline alphoscerate (α-GPC), a cholinergic neurotransmission-enhancing agent, protects from Aβ-mediated neurotoxicity. Herein, we investigated the effects of α-GPC on the microglial phenotype in response to Aβ via modulation of the nicotinic alpha-7 acetylcholine receptor (α7 nAChR). BV2 microglial cells were pre-treated for 1 h with α-GPC and were treated for 24, 48, and 72 h with Aβ1–42 and/or α-BTX, a selective α7nAchR antagonist. Fluorescent immunocytochemistry and Western blot analysis showed that α-GPC was able to antagonize Aβ-induced inflammatory effects. Of note, α-GPC exerted its anti-inflammatory effect by directly activating the α7nAChR receptor, as suggested by the induction of an increase in [Ca2+]i and Ach-like currents. Considering that cholinergic transmission appears crucial in regulating the inflammatory profiles of glial cells, its modulation emerges as a potential pharmaco-therapeutic target to improve outcomes in inflammatory neurodegenerative disorders, such as AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pharmacology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
- Clinical Toxicology Unit, University Hospital of Catania, 95123 Catania, Italy.
- Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy.
ORCID-Profile: Chiara Burgaletto, Giulia Di Benedetto, Agnese Secondo, Carlo Maria Bellanca, Egle Augello, Antonio Munafò, Giuseppina Cantarella
Förderung
- Italian Ministry of Research
Zitieren
APA
Cantone, A. F., Burgaletto, C., Di Benedetto, G., Pannaccione, A., Secondo, A., Bellanca, C. M., Augello, E., Munafò, A., Tarro, P., Bernardini, R., & Cantarella, G. (2024). Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation. Cells. https://doi.org/10.3390/cells13040309
Vancouver
Cantone AF, Burgaletto C, Di Benedetto G, Pannaccione A, Secondo A, Bellanca CM, et al. Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation. Cells. 2024. doi:10.3390/cells13040309
BibTeX
@article{Cantone2024,
author = {Cantone, Anna Flavia and Burgaletto, Chiara and Di Benedetto, Giulia and Pannaccione, Anna and Secondo, Agnese and Bellanca, Carlo Maria and Augello, Egle and Munafò, Antonio and Tarro, Paola and Bernardini, Renato and Cantarella, Giuseppina},
title = {Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13040309}
}
EUVIMED